International Association of Stem Cell and Regenerative Medicine
IASRM is a New Delhi-based, for-profit community organization founded in 2020 that focuses on stem cell technology, cellular therapy, and regenerative medicine, serving an international constituency of researchers and clinicians under President Prabhu Mishra.
- Company typePrivate
- Founded2020
- HeadquartersNew Delhi, India
- Headcount11–50
- GTM typeB2B
- OfferingServices
What International Association of Stem Cell and Regenerative Medicine does
The International Association of Stem Cell and Regenerative Medicine (IASRM) is a for-profit organization described as a community focused on stem cell technology, cellular therapy, and regenerative medicine. Founded in 2020 and headquartered in New Delhi, India, it operates with a small team of 11–50 employees under the leadership of President Prabhu Mishra. Its "international" branding and global domain (iasrmglobal.org) indicate an intent to serve a cross-border constituency of researchers, clinicians, and industry participants in the regenerative medicine field, despite the absence of any disclosed overseas offices, chapters, or operational footprint.
The organization's website returned only a verification/loading page at the time of data collection, and no substantive information on products, services, membership programs, conferences, certifications, partnerships, technology platforms, or proprietary assets was available from the source material. There is no disclosed product portfolio, technology stack, AI/ML capability, or research output in the input data, and no funding rounds, revenue figures, pricing, customer segments, or strategic transactions have been reported. The only verifiable operational detail beyond the firmographic profile is the leadership appointment of Prabhu Mishra as President.
The business model is not documented in the available sources. No revenue mechanics — such as membership dues, conference/event fees, sponsorships, training programs, certification revenues, or grant funding — are disclosed, nor is the customer or member base quantified or segmented. In effect, the organization's commercial activity, scale of operations, and go-to-market mechanics remain opaque from the current data set, and any deeper conclusion on revenue model, customer profile, or technology depth cannot be drawn without primary-source access to the organization.
International Association of Stem Cell and Regenerative Medicine firmographics
Firmographics- Name
- International Association of Stem Cell and Regenerative Medicine
- Website
- https://iasrmglobal.org
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IASRM is a New Delhi-based, for-profit community organization founded in 2020 that focuses on stem cell technology, cellular therapy, and regenerative medicine, serving an international constituency of researchers and clinicians under President Prabhu Mishra.
- Ownership category
- akta.pro rank
Where International Association of Stem Cell and Regenerative Medicine is headquartered
LocationHeadquarters
- HQ city
- New Delhi
- HQ country
- India
- HQ region
- Asia
Markets served
International Association of Stem Cell and Regenerative Medicine business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
International Association of Stem Cell and Regenerative Medicine product offering
Product offeringCore offering
IASRM operates as a community and association focused on stem cell technology, cellular therapy, and regenerative medicine. It convenes professionals, researchers, and institutions working in these converging disciplines to enable collaboration, knowledge-sharing, and professional engagement.
Differentiator
Problem solved
Functional benefit
Products and services
- IASRM Community Membership Membership-based access to a professional community and association dedicated to stem cell technology, cellular therapy, and regenerative medicine, intended for researchers, clinicians, and institutions active in these fields.
Companies that use International Association of Stem Cell and Regenerative Medicine
Customer profileIdeal customer profiles1 record
International Association of Stem Cell and Regenerative Medicine technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
International Association of Stem Cell and Regenerative Medicine partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
International Association of Stem Cell and Regenerative Medicine competitors and assessment
Company assessmentBroad incumbents
- EuroStemCell: Well-funded European stem cell research and education initiative. Comparable to IASRM as a community-facing stem cell organization, but with significantly broader institutional backing and established public engagement infrastructure.
- New York Stem Cell Foundation (NYSCF): Major non-profit supporting stem cell research, convening the field, and publishing. Comparable to IASRM as a regenerative medicine community organization, with substantially larger resources and brand recognition.
Emerging players
- American Association of Stem Cell Physicians: A physician-focused stem cell association serving clinicians in the regenerative medicine space. Comparable to IASRM in mission but narrower in geographic and professional scope (U.S.-physician centric).
- International Society for Stem Cell Application: An emerging organization focused on clinical and commercial stem cell applications. Comparable to IASRM as a younger society targeting translational and clinical stem cell audiences, though with somewhat different geographic and clinical emphases.
Direct peers
- Alliance for Regenerative Medicine (ARM): International advocacy and industry organization representing the regenerative medicine and advanced therapies sector. Comparable as a membership-based body serving the same regenerative medicine community, with a stronger industry and policy orientation.
- Tissue Engineering and Regenerative Medicine International Society (TERMIS): International scientific society for tissue engineering and regenerative medicine. Directly comparable to IASRM in scientific scope, conference programming, and membership model.
- International Society for Cell & Gene Therapy (ISCT): Global professional society focused on cell and gene therapy translation. Overlaps with IASRM on cellular therapy and regenerative medicine practitioners, and competes for the same members, sponsors, and conference visibility.
- International Society for Stem Cell Research (ISSCR): The leading global scientific society for stem cell research, with a member base of thousands of scientists and clinicians. Directly comparable to IASRM as a stem-cell-focused membership organization competing for the same scientific and clinical audience.
- Regenerative Medicine Foundation: Non-profit foundation advocating for and convening the regenerative medicine field. Comparable as an association-style organization operating in the same scientific and policy space as IASRM.
Regional players
- International Society for Cell Therapy — Asia Pacific Chapter: Regional chapter of ISCT serving the Asia-Pacific cell therapy community. Most comparable to IASRM given overlapping Asia-Pacific geographic focus and cell therapy scope, and a credible competing convening body for IASRM's India-rooted base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
International Association of Stem Cell and Regenerative Medicine social profiles
Digital presenceInternational Association of Stem Cell and Regenerative Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
International Association of Stem Cell and Regenerative Medicine leadership team
Management profileNumber of profiles
Profiles1 record
International Association of Stem Cell and Regenerative Medicine funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
International Association of Stem Cell and Regenerative Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about International Association of Stem Cell and Regenerative Medicine
What does International Association of Stem Cell and Regenerative Medicine do?
IASRM operates as a community and association focused on stem cell technology, cellular therapy, and regenerative medicine. It convenes professionals, researchers, and institutions working in these converging disciplines to enable collaboration, knowledge-sharing, and professional engagement.
When was International Association of Stem Cell and Regenerative Medicine founded?
International Association of Stem Cell and Regenerative Medicine was founded in 2020. It employs 11 to 50 people.
Where is International Association of Stem Cell and Regenerative Medicine based?
International Association of Stem Cell and Regenerative Medicine is headquartered in New Delhi, India, in the Asia region.
Who are International Association of Stem Cell and Regenerative Medicine's main competitors?
Broad incumbents on record are EuroStemCell and New York Stem Cell Foundation (NYSCF). Emerging players are American Association of Stem Cell Physicians and International Society for Stem Cell Application. Direct peers are Alliance for Regenerative Medicine (ARM), Tissue Engineering and Regenerative Medicine International Society (TERMIS), International Society for Cell & Gene Therapy (ISCT), International Society for Stem Cell Research (ISSCR) and Regenerative Medicine Foundation. International Society for Cell Therapy — Asia Pacific Chapter is listed as a regional player.
Does International Association of Stem Cell and Regenerative Medicine have an API?
No public API is recorded for International Association of Stem Cell and Regenerative Medicine.